NOVOCART 3D
Commercial- Indications
- Cartilage repair
Company intelligence / Profile preview
Aesculap Biologics
Breinigsville, Pennsylvania, USAaesculapusaifus.com ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Commercial
01
Overview
Aesculap Biologics is focused on regenerative medicine, particularly in repairing and regenerating damaged tissues. Their products include NOVOCART 3D for cartilage defects and solutions for back pain.
- Therapeutic areas
- Rheumatology
- Modalities
- Cell therapyTissue-engineered products
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Aesculap Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aesculap Biologics.